Xeureka Aims To Accelerate Durg Research And Development
Xeureka, wants to speed up the healthcare industry’s billion-dollar, ten-year drug development process research and development
Xeureka has already finished a proof of concept that tackles one of the main issues with drug discovery gathering sufficient data
Using security management software from Fortanix, one of the first firms to provide secret computing, Xeureka tested on NVIDIA H100 Tensor Core GPUs
Xeureka is working with the community behind Tokyo-1, its GPU-accelerated AI supercomputer, to investigate wide-ranging uses of this technology in drug discovery
Tokyo-1 users may use NVIDIA BioNeMo, drug discovery microservices and framework to apply large language model
An AI model was trained using the datasets of each firm independently to forecast the toxicity levels of the compounds
The bulk of they work is carried out in partnership with IT firms, in this example Fortanix, a security software business located in San Francisco, and NVIDIA